Abstract
Alanine and taurine sharply potentiate antiaggregant effects of hypochlorite on platelets in platelet-rich plasma. This effect is determined by more pronounced action of chloramine derivatives, products of interaction of added amino acids with hypochlorite. Platelets are more sensitive to the inhibitory effects of amino acid chloramine derivatives (biogenic chloramines) compared to erythrocytes and neutrophils. The antiaggregant effects of biobenic amines, as covalent platelet inhibitors, in platelet-rich plasma are characterized by their increased reaction capacity with molecular targets in cells. Quantitative parameter of this initial selectivity (ratio of rate constant of inactivation of platelet receptors to rate constant of side reaction with plasma proteins) far surpasses 1. N,N-Dichlorotaurine is a perspective antiaggreant among the studied biogenic chloramines. This agent is stable and exhibits specific pharmacological activity in all test systems, including animal model of thrombosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. A. Murina, N. S. Belakina, and D. I. Roshchupkin, Biofizika, 49, No. 6, 1099–1105 (2004).
M. A. Murina, D. I. Roshchupkin, N. N. Kravchenko, and V. I. Sergienko, Ibid., No. 6, 1279–1285 (1997).
M. A. Murina, E. L. Savel’eva, and D. I. Roshchupkin, Ibid., 51, No. 2, 299–305 (2006).
M. A. Murina, V. I. Sergienko, and D. I. Roshchupkin, Molecular, Membrane, and Cellular Bases of Biosystem Functioning [in Russian], Minsk (2006), pp. 221–223.
M. A. Murina, O. D. Fesenko, V. I. Sergienko, et al., Byull. Eksp. Biol. Med., 134, No. 7, 44–47 (2002).
M. A. Murina, N. A. Chudina, D. I. Roshchupkin, et al., Ibid., 138, No. 12, 632–634 (2004).
Patent of Russian Federation No. 2161483, M. A. Murina, D. I. Roshchupkin, and V. I. Sergienko, Official Bulletin of Patent and Trademark Committee of the Russian Federation, (2001), No. 1, (reg. 10.01.01, priority from 04.02.98).
Patent of Russian Federation No. 1834659, M. A. Murina, D. I. Roshchupkin, and V. I. Sergienko, Ibid, (1993), No 30, p. 62, (reg. 13.10.92, priority from 18.04.88).
D. I. Roshchupkin, V. V. Berzhitskaya, and M. A. Murina, Biofizika, 43, No. 2, 323–328 (1998).
D. I. Roshchupkin, M. A. Murina, N. N. Trunilina, and V. I. Sergienko, Ibid., 40, No. 3, 569–575 (1995).
D. I. Roshchupkin, M. A. Murina, N. V. Adnoral, et al., Fiziol. Cheloveka, No. 3, 113–120 (1998).
Patent of Russian Federation No. 2067764, D. I. Roshchupkin and A. Yu. Sokolov, Official Bulletin of Patent and Trademark Committee of the Russian Federation, No. 28, 225 (1996).
F. Dallegri, A. Ballestrero, G. Frumento, and F. Patrone, J. Clin. Lab. Immunol., 20, 37–41 (1986).
M. B. Grisham, M. M. Jefferson, and E. L. Thomas, J. Biol. Chem., 259, No. 11, 6757–6772 (1984).
I. Koyama, K. Nakamori, T. Nagahama, et al., Adv. Exp. Med. Biol., 403, 9–18 (1996).
P. Latimer, Appl. Optics., 22, 1136–1143 (1983).
J. Marcinkiewicz, A. Grabowska, J. Bereta, and T. Stelmaszynska, J. Leukoc. Biol., 58, 667–674 (1995).
J.-M. Pereillo, M. Maftouh, A. Andrieu, et al., Drug Metab. Dispos., 30, No. 11, 1288–1295 (2002).
A. Slivka, A. F. LoBuglio, and S. J. Weiss, Blood, 55, No. 2, 347–350 (1980).
E. L. Thomas, Infect. Immun., 25, No. 1, 110–116 (1979).
E. L. Thomas, P. M. Bozeman, M. M. Jefferson, and C. C. King, J. Biol. Chem., 270, No. 7, 2906–2913 (1995).
E. L. Thomas, M. B. Grisham, and M. M. Jefferson, J. Clin. Invest., 72, No. 2, 441–454 (1983).
H. Wahn and S. Hammerschmidt, Biochim. Biophys. Acta., 1408, No. 1, 55–66 (1998).
C. E. Wright, H. H. Tallan, Y. Y. Lin, G. E. Gaull, Annu. Rev. Biochem., 55, 427–453 (1986).
K. K. Wu, Semin. Vasc. Med., 3, No. 2, 107–112 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Supplement 2, pp. 94–100, April, 2007
Rights and permissions
About this article
Cite this article
Murina, M.A., Roshchupkin, D.I., Kravchenko, N.N. et al. Antiaggregant effects of biogenic chloramines. Bull Exp Biol Med 144, 464–470 (2007). https://doi.org/10.1007/s10517-007-0352-z
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-007-0352-z